Circulars

30 April 2020

Safety Alerts for Pharmaceutical Products & Medical Devices

Reference: CIR-2020-00000064

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

  • Drug Safety communication Due to possible increased risk of cancer. Belviq XR (lorcaserin)l
  • Safety Alerts for medical device Atellica CH Reaction Cuvette Segment

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Drug Safety communication Due to possible increased risk of cancer. Belviq XR (lorcaserin.pdf:

View Document

Safety Alerts for medical device Atellica CH Reaction Cuvette Segment.pdf:

View Document